INTRODUCTION
============

Acute generalized exanthematous pustulosis (AGEP) is an acute febrile rash, characterized by numerous small non-follicular and sterile pustules on erythematous base.^[@r1]-[@r3]^

Over 90% of the cases are induced by drugs. Occasionally, AGEP is caused by infections and exposure to mercury and rarely it may be the consequence of a spider bite, as in the case reported.^[@r4],[@r5]^

CASE REPORT
===========

Male patient, 48 years old, from the metropolitan area of Porto Alegre (RS), sought medical attention due to disseminated erythematous lesions and fever for the past four days.

He reported a spider bite in the right buttock region. The spider was not found and the patient reported pain in the area while sleeping in his beach house. In 48 hours a violaceous spot appeared on the site.

On the third day he presented an erythematous eruption accompanied by several disseminated small non-follicular pustules, fever over 38ºC and pruritus ([Figure 1](#f1){ref-type="fig"}).

Figure 1Erythema and pustules on the abdômen

The gluteal lesion evolved, in four days, with the onset of a necrotic plaque, dry and well delimited. The edema and erythema adjacent to the lesion increased ([Figure 2](#f2){ref-type="fig"}). The patient denied use of painkillers or other drugs. Since infection was suspected, cephalexin was prescribed.

He presented leukocytosis (27,260 leukocytes, with predominance of neutrophils) and increased transaminases (ALT 268; AST 56), GGT (366) and bilirubin (TB 2.5, IB 1.7, DB 0.8). As viral serology was negative and the diagnosis was AGEP, treatment was begun with prednisone (80 mg / day).

Figure 2Necrotic plaque on the right buttock, surrounded by erythema and non-follicular pustules

The clinical picture progressed with diffuse desquamation and periorbital edema ([Figure 3](#f3){ref-type="fig"}), as well as of hands and feet. On palms and plants, there was the onset of blisters with later desquamation. There was clinical and laboratorial improvement, which prompted gradual decrease of prednisone until its suspension. The buttock lesion evolved with detachment of the necrotic plaque and local ulcer.

Histopathology showed pustular dermatitis with neutrophilic vasculitis, focally purpuric, discrete edema in the dermal papillae and absence of leukocytoclasia ([Figures 4](#f4){ref-type="fig"} and [5](#f5){ref-type="fig"}).

Figure 3Desquamation of back

Figure 4Intraepidermal pustule and mild spongiosis. Discreet edema of dermal papillae and inflammatory perivascular infiltrate in the derm (hematoxilin-eosin, 40x to the left and 100x to the right)

Figure 5Vessel in the derm with inflammatory perivascular infiltrate, predominantly neutrophilic, with some lymphocytes (hematoxilin-eosin, 100x)

DISCUSSION
==========

The *Loxosceles* genus can be found all over Brazil, mainly in the state of Parana. They are small spiders, non-agressive, of nocturnal habits that bite when compressed against the human body.^[@r2],[@r6]^ The diagnosis of loxoscelism is rarely based on the identification of the spider. Unless the patient captures the spider and brings it over for identification, the diagnosis is presumptive. In Brazil, 10,000 cases of *Loxosceles* bites are reported annually.^[@r6],[@r7]^

The bite is painless and causes local edema and erythema. There may be onset of ecchymotic areas mixed with paleness, blisters or necrosis. The lesion is prone to progress gravitationally, due to the action of hyaluronidase present in the venom.^[@r7]^

Systemic loxoscelism is rare and commonly associated with discreet symptoms, such as malaise and myalgia. There may also be mild hemolysis or, rarely, in the more severe forms, hemolytic anemia and acute renal lesion caused by severe hemolysis.^[@r5],[@r6]^

In spite of the uniformity of the initial lesion being not characteristic, its evolution with detachment of the necrotic plaque and formation of ulcer is compatible with *Loxosceles* spider bite, especially because it is an endemic area.^[@r6],[@r7]^

Exanthema following spider bite is uncommon. It occurs in 72 hours and is characterized as morbiliform or scarlatiniform rash.^[@r8]^ Palpable purple, pustular exanthema and even a mix of these two findings have been described.^[@r8]^

Recently, *Loxosceles* bite has been linked to AGEP.^[@r1]-[@r5]^ The triggering of AGEP after spider bite is rare, and its mechanism is not well understood.

In the pathogenesis of AGEP, IL-8 (interleukin-8) and GMCSF (Granulocyte-macrophage colony-stimulating factor) are implicated in polymorphonuclear recruiting for the epidermis. IL-8 is produced by keratinocytes and T-cells. The venom of this spider contains sphingomyelinase, which stimulates the liberation of cytokines, including a great amount of IL-8 and GM-CSF, which would trigger AGEP.^[@r2]^

The clinical picture of AGEP is characterized by the abrupt onset of erythema and edema in intertriginous areas or in the face, with craniocaudal dissemination and the arising of hundreds of small non-follicular and sterile pustules. It may be preceded or accompanied by high fever and pruritus. Pustules have an average duration of nine days, evolving with desquamation. Multiform erythema-type lesions, edema of face and hands, purpura, vesicles, blisters and involvement of mucosae are additional findings, some of them found in the case described.^[@r1],[@r9],[@r10]^

Histology may reveal spongiosis and subcorneal or intraepidermal pustules. There is edema in the dermal papillae, which may vary in intensity, neutrophils and eosinophils perivascular infiltrate and, sometimes, leukocytoclastic vasculitis. There may be focal necrosis of keratinocytes.^[@r1],[@r9],[@r10]^

In the complementary evaluation, there may be leukocytosis, with predominance of neutrophils and eosinophils, transitory loss of renal function and increased aminotransferases, findings that would justify some laboratorial changes found in the case described.^[@r1]^

According to EuroSCAR group\'s scoring system (*European project dedicated to severe cutaneous adverse reactions*), used in the identification of AGEP cases, the patient scored +10, indicating definite diagnosis of AGEP ([Table 1](#t1){ref-type="table"}).^[@r9]^

###### 

AGEP score of patient determined by the use of criteria from EuroSCAR study group

  Criteria                            Description                                                                      Score
  ----------------------------------- -------------------------------------------------------------------------------- ---------
  **Morphology**                                                                                                        
      Pustules                        Typical, non-follicular and sterile                                              +2
      Erythema                        Typical, diffuse                                                                 +2
      Distribution                    Compatible, trunk and members                                                    +1
      Desquamation post-pustulation   Yes                                                                              +1
      Additional findings             No                                                                                
  **Course**                                                                                                            
      Mucosal involvement             No                                                                               0
      Acute start (\< 10 days)        Yes                                                                              0
      Resolution \< 15 days           Yes                                                                              0
  **    Fever (≥ 38 ºC)**             **Yes**                                                                          **+1**
      Polymorphonuclear (≥ 7.000)     Yes                                                                              +1
  **Histopathology**                                                                                                    
      Biopsy of skin                  Intraepidermal pustule with dermal edema, perivascular neutrophilic infiltrate   +2
  **TOTAL SCORE**                                                                                                      **+10**

Interpretation according to final score: ≤ 0: absence of AGEP; 1-4: possible AGEP; 5-7: probable AGEP; 8-12: AGEP as certain diagnosis

As the patient had a lesion compatible with *Loxosceles* spider bite, without presenting other known AGEP triggers in a region where this spider is endemic, the conclusion was that AGEP would be associated with spider bite, as described in other publications.^[@r2],[@r4],[@r5],[@r8]^

The increase of bilirubins may be attributed to mild hemolysis, frequently found in loxoscelism.^[@r6]^

There is a report that histologically characterizes the exanthema after spider bite not linked to AGEP as necrotizing vasculitis, similar to the one observed in the bite area, but without epidermal necrosis.^[@r8]^ These alterations were not found in our patient, whose anatomopathological results were compatible with AGEP.

The prognosis of AGEP is good when triggered by medication.^[@r1]^ Due to few reports of cases linked to spider bite, it is not clear if there is alteration of the prognostic.

Other reports had their etiological diagnosis made difficult by the simultaneous and early use of antibiotics. In this report, as the patient started their use when he already presented lesions with AGEP characteristics, the antibiotic did not seem relevant in triggering the pathology.

Treatment is symptomatic.^[@r1]^ A short course of systemic corticoid may be considered in severe cases, but usually it is not necessary, due to the self-limiting character of lesions.^[@r3],[@r10]^

This report of AGEP associated with spider bite aims to point out to this rare triggering factor in Brazil, where incidents by *Loxosceles* bites are frequent.
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